Biogened SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLBIOGN00018
PLN
21.60
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
BIOTON SA
Biogened SA
Celon Pharma SA
Ryvu Therapeutics SA
Captor Therapeutics SA
Synthaverse SA
Bioceltix SA
Molecure SA
E-shopping Group SA
Why is Biogened SA ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 8.84% signifying low profitability per unit of shareholders funds
2
Negative results in Mar 25
  • INTEREST(Q) Highest at PLN 1.03 MM
3
With ROE of 10.45%, it has a fair valuation with a 1.33 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 10.77%, its profits have risen by 2.5% ; the PEG ratio of the company is 5.2
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 10.77% in the last 1 year, much lower than market (Poland WIG) returns of 37.76%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Biogened SA should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Biogened SA for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Biogened SA
8.0%
0.13
69.85%
Poland WIG
39.24%
1.84
20.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
18.77%
EBIT Growth (5y)
17.39%
EBIT to Interest (avg)
4.85
Debt to EBITDA (avg)
1.29
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
1.72
Tax Ratio
33.00%
Dividend Payout Ratio
42.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.92%
ROE (avg)
8.84%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.33
EV to EBIT
9.58
EV to EBITDA
6.30
EV to Capital Employed
1.23
EV to Sales
0.69
PEG Ratio
5.19
Dividend Yield
105.04%
ROCE (Latest)
12.85%
ROE (Latest)
10.45%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -2.99% (YoY

CASH AND EQV(HY)

Highest at PLN 10.92 MM

DEBT-EQUITY RATIO (HY)

Lowest at 37.29 %

NET SALES(Q)

Highest at PLN 32.85 MM

PRE-TAX PROFIT(Q)

Highest at PLN 3.45 MM

NET PROFIT(Q)

Highest at PLN 2.31 MM

EPS(Q)

Highest at PLN 0.94

-3What is not working for the Company
INTEREST(Q)

Highest at PLN 1.03 MM

Here's what is working for Biogened SA
Net Sales
Highest at PLN 32.85 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (PLN MM)

Pre-Tax Profit
Highest at PLN 3.45 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (PLN MM)

Net Profit
Highest at PLN 2.31 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (PLN MM)

EPS
Highest at PLN 0.94
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (PLN)

Cash and Eqv
Highest at PLN 10.92 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at 37.29 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -2.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at PLN 1.08 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (PLN MM)

Here's what is not working for Biogened SA
Interest
At PLN 1.03 MM has Grown at 553.11%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (PLN MM)

Interest
Highest at PLN 1.03 MM
in the last five periods and Increased by 553.11% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (PLN MM)